Brief: Wuxi Biologics Posts FY Profit Attributable Of RMB3,399.7 Mln
March 26 (Reuters) - WuXi Biologics (Cayman) Inc
2269.HK :
* DOES NOT RECOMMEND ANY PAYMENT OF FINAL DIVIDEND
* FY PROFIT ATTRIBUTABLE RMB3,399.7 MILLION VERSUS
RMB4,420.3
MILLION
Further company coverage: 2269.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln